FSSAI notice on ‘100%’ claims sends Dabur shares down nearly 4%
FSSAI has directed Dabur India to discontinue disputed “100 per cent” claims on products including honey, oils, ghee and coconut water unless they meet compliance requirements. Dabur said it is reviewing the notice as its stock neared its 52-week low.
What happened
Dabur India · FSSAI directed Dabur to stop using unsubstantiated “100 per cent” claims on products including honey, oils, ghee and coconut water. Dabur is
Key facts
- Dabur shares fell nearly 4% to Rs 406.15 from Rs 424.40
- Market capitalisation fell to Rs 72,288 crore
- 52-week low: Rs 401.05 on March 30, 2026
- Stock fell 35% over two years and 28% over three years; gained 38% over 10 years
Why this matters
For acquirers and partners, the case elevates regulatory diligence around claim substantiation, product portfolios and potential brand-liability exposure in FMCG deals.
What to watch
- Dabur’s formal response, appeal or confirmation of label changes.
- Whether FSSAI names additional brands, categories or specific non-compliance findings.
- Scale of packaging write-offs, promotional spending and gross-margin commentary in Dabur’s next earnings update.
- Changes to marketplace listings, retailer shelf tags and advertising creatives for honey, oils, ghee and coconut water.
- Consumer-social-media traction, complaint volumes or litigation related to product purity claims.
- Any enforcement guidance defining acceptable use of '100%', 'pure', 'natural' or similar absolute labels.
- Audit all absolute, purity and composition claims across Dabur’s food, beverage, ayurvedic and personal-care portfolio, not only the named SKUs.
- Issue revised pack, e-commerce and advertising copy with substantiation files prepared for FSSAI and retailer compliance teams.
- Prioritise depletion or controlled rework of existing labelled inventory to avoid channel disruption and write-offs.
- Increase communication around tested quality, sourcing and regulatory compliance without repeating disputed absolute claims.
- Monitor peer products for similar claims; competitive response may shift from purity superlatives toward certifications, traceability and ingredient disclosure.